Literature DB >> 6418636

Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism.

M Cazzola, E Ascari, G Barosi, G Claudiani, M Daccó, J P Kaltwasser, N Panaiotopoulos, K P Schalk, E E Werner.   

Abstract

It is generally believed that idiopathic haemochromatosis is exclusively a disease of middle age, affecting primarily men. We describe here four cases of idiopathic haemochromatosis having onset of symptoms before or around the age of 20 years. Other similar cases have previously been reported. In this juvenile form, males and females appear to be equally affected. These subjects may have a history of unexplained abdominal pain, present with hypogonadotropic hypogonadism, and, unless proper treatment is started, die early because of cardiac dysfunction. In this regard, their clinical course is very similar to that of well-transfused thalassemia major. Thus, early diagnosis is even more important in the juvenile form than in the adult form of idiopathic haemochromatosis. We suggest that evaluation of body iron stores should be performed as a screening procedure in young subjects with hypogonadotropic hypogonadism and/or cardiac dysfunction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418636     DOI: 10.1007/BF00286653

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

1.  IDIOPATHIC HAEMOCHROMATOSIS IN CHILDREN; REPORT OF A FAMILY.

Authors:  K W PERKINS; I W MCINNES; C R BLACKBURN; R W BEAL
Journal:  Am J Med       Date:  1965-07       Impact factor: 4.965

Review 2.  HLA and disease 1982--a survey.

Authors:  A Svejgaard; P Platz; L P Ryder
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

3.  The prolactin response to thyrotropin-releasing hormone differentiates isolated gonadotropin deficiency from delayed puberty.

Authors:  I M Spitz; H J Hirsch; S Trestian
Journal:  N Engl J Med       Date:  1983-03-10       Impact factor: 91.245

4.  Hemochromatosis in two young sisters. Case studies and a family survey.

Authors:  J H Felts; J R Nelson; C N Herndon; C L Spurr
Journal:  Ann Intern Med       Date:  1967-07       Impact factor: 25.391

5.  Idiopathic hemochromatosis in young subjects. Clinical, pathological, and chemical findings in four patients.

Authors:  R W Charlton; C Abrahams; T H Bothwell
Journal:  Arch Pathol       Date:  1967-02

6.  Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis.

Authors:  S C FINCH; C A FINCH
Journal:  Medicine (Baltimore)       Date:  1955-12       Impact factor: 1.889

7.  Gonadotropin insufficiency in patients with thalassemia major.

Authors:  O A Kletzky; G Costin; R P Marrs; G Bernstein; C M March; D R Mishell
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

Review 8.  Idiopathic hemochromatosis, an interim report.

Authors:  M S Milder; J D Cook; S Stray; C A Finch
Journal:  Medicine (Baltimore)       Date:  1980-01       Impact factor: 1.889

9.  Idiopathic hemochromatosis in a young female. A case study and review of the syndrome in young people.

Authors:  J M Lamon; S P Marynick; R Roseblatt; S Donnelly
Journal:  Gastroenterology       Date:  1979-01       Impact factor: 22.682

10.  Genetic linkage between hereditary hemochromatosis and HLA.

Authors:  K Kravitz; M Skolnick; C Cannings; D Carmelli; B Baty; B Amos; A Johnson; N Mendell; C Edwards; G Cartwright
Journal:  Am J Hum Genet       Date:  1979-09       Impact factor: 11.025

View more
  10 in total

1.  Haemochromatosis as an endocrine cause of subfertility.

Authors:  M J Tweed; J M Roland
Journal:  BMJ       Date:  1998-03-21

Review 2.  The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.

Authors:  Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2017-11-13       Impact factor: 2.490

Review 3.  Osteoporosis in HFE2 juvenile hemochromatosis. A case report and review of the literature.

Authors:  Nicholas G Angelopoulos; Anastasia K Goula; George Papanikolaou; George Tolis
Journal:  Osteoporos Int       Date:  2005-07-05       Impact factor: 4.507

4.  Successful treatment by gonadotrophins of a patient with genetic haemochromatosis and infertility.

Authors:  P L Selvais; J Henrion
Journal:  Postgrad Med J       Date:  1993-03       Impact factor: 2.401

5.  Atypical haemochromatosis: phenotypic spectrum and beta2-microglobulin candidate gene analysis.

Authors:  A P Walker; D F Wallace; J Partridge; A B Bomford; J S Dooley
Journal:  J Med Genet       Date:  1999-07       Impact factor: 6.318

6.  Iron Overload (with Attention to Genetic Testing and Diagnosis/Management of HFE Wild Type Patients).

Authors:  Narendra Siddaiah; Kris V Kowdley
Journal:  Curr Treat Options Gastroenterol       Date:  2006

Review 7.  Is genetic screening for hemochromatosis worthwhile?

Authors:  Omer T Njajou; Behrooz Z Alizadeh; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

8.  All that is hypogonadal in haemochromatosis is not due to iron deposition.

Authors:  E P O'Sullivan; J H McDermott; C Howel Walsh
Journal:  Ir J Med Sci       Date:  2007-03       Impact factor: 1.568

9.  Juvenile hemochromatosis locus maps to chromosome 1q.

Authors:  A Roetto; A Totaro; M Cazzola; M Cicilano; S Bosio; G D'Ascola; M Carella; L Zelante; A L Kelly; T M Cox; P Gasparini; C Camaschella
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

10.  A late presentation of a fatal disease: juvenile hemochromatosis.

Authors:  Cynthia Cherfane; Pauline Lee; Leana Guerin; Kyle Brown
Journal:  Case Rep Med       Date:  2013-09-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.